CD8A and lymphoma: Administration of IL-10 to lymphoma-bearing mice significantly curtailed tumor growth, with a noteworthy rise in memory CD8 + T cells in comparison to non-IL-10-injected mice, suggesting IL-10’s to enhance anti-tumor effects, immunity, and conceivably play a role in cancer recurrence prevention38.